Trials / Completed
CompletedNCT06333028
A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract Extraction
Detailed description
A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | enVista Aspire EA IOLs | Subjects bilaterally implanted with enVista Aspire EA IOLs |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2025-03-13
- Completion
- 2025-03-13
- First posted
- 2024-03-27
- Last updated
- 2025-05-02
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06333028. Inclusion in this directory is not an endorsement.